Company: SACH
Filing Date: 2025-11-14
Form Type: 424B2
Source: 0001628280-25-052333
Chunk: 10

Company: Sachem Capital Corp.
Filing Date: 2025-11-14
Form: 424B2
Chunk 10
---
 brief summary of some of those risks). If any of these risks occur, our business, financial condition, liquidity, results of operations, prospects, and ability to make distributions to our shareholders could be materially and adversely affected. In that case, the trading price of our securities could decline, and you may lose a portion or your entire investment.

#### Corporate Information
Our principal executive offices are currently located at 568 East Main Street, Branford, Connecticut 06405, and our telephone number is (203) 433-4736. The URL for our website is www.sachemcapitalcorp.com . The information contained on or connected to our website is not incorporated by reference into, and you must not consider the information to be a part of, this Prospectus Supplement.

<div align='center'>S-5</div>

THE OFFERING

| Issuer                                 |     | Sachem Capital Corp.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Securities Offered                     |     | Shares of our 7.75% Series A Cumulative Redeemable Preferred Stock, par value $0.001 per share, having an aggregate offering price of up to $18,450,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Manner of Offering                     |     | We have entered into an At the Market Issuance Sales Agreement, or the Sales Agreement, with Ladenburg Thalmann & Co., Inc. and Lucid Capital Markets, LLC referred to herein, collectively, as the “Selling Agents,” relating to the sale of the shares offered by this Prospectus Supplement. In accordance with the terms of the Sales Agreement, under this Prospectus Supplement we may offer and sell shares of our Series A Preferred Stock having an aggregate offering price of up to $18,450,000 from time to time through the Selling Agents. Sales of shares, if any, under this Prospectus Supplement will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act of 1933, as amended. See the section entitled “Plan of Distribution” on pageS-37of this Prospectus Supplement. |
| Use of Proceeds                        |     | We intend to use the net proceeds of this offering for working capital general corporate purposes. See the section entitled “Use of Proceeds” on pageS-20of this Prospectus Supplement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Risk Factors                           |     | Investing in our Series A Preferred Stock involves risks. You should